Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics

Show other versions (1)

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in t...

Full description

Bibliographic Details
Main Authors: Kok Gan Chan, Geik Yong Ang, Choo Yee Yu, Chan Yean Yean
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Life
Subjects:
coronavirus
COVID-19
isothermal amplification
antiviral
CRISPR-Dx
Online Access:https://www.mdpi.com/2075-1729/11/11/1210

Similar Items

Similar Items